News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
584,254 Results
Type
Article (31509)
Company Profile (234)
Press Release (552511)
Multimedia
Podcasts (62)
Webinars (10)
Section
Business (165171)
Career Advice (772)
Deals (27712)
Drug Delivery (55)
Drug Development (80718)
Employer Resources (71)
FDA (14699)
Job Trends (12089)
News (288197)
Policy (22897)
Tag
Academia (2231)
Academic (1)
Accelerated approval (6)
Adcomms (27)
Allergies (83)
Alliances (45861)
ALS (96)
Alzheimer's disease (1404)
Antibody-drug conjugate (ADC) (144)
Approvals (14697)
Artificial intelligence (295)
Autoimmune disease (21)
Automation (13)
Bankruptcy (201)
Best Places to Work (10273)
BIOSECURE Act (14)
Biosimilars (70)
Biotechnology (179)
Bladder cancer (78)
Brain cancer (28)
Breast cancer (291)
Cancer (2297)
Cardiovascular disease (173)
Career advice (674)
Career pathing (19)
CAR-T (161)
Cell therapy (442)
Cervical cancer (21)
Clinical research (66514)
Collaboration (859)
Company closure (1)
Compensation (458)
Complete response letters (22)
COVID-19 (2316)
CRISPR (49)
C-suite (243)
Cystic fibrosis (104)
Data (2308)
Decentralized trials (2)
Denatured (29)
Depression (48)
Diabetes (248)
Diagnostics (6378)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (19)
Drug discovery (120)
Drug pricing (32)
Drug shortages (12)
Duchenne muscular dystrophy (87)
Earnings (62306)
Editorial (20)
Employer branding (10)
Employer resources (64)
Events (92365)
Executive appointments (716)
FDA (16009)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (759)
Gene editing (120)
Generative AI (28)
Gene therapy (302)
GLP-1 (579)
Government (2723)
Grass and pollen (4)
Guidances (134)
Healthcare (16542)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (111)
Indications (30)
Infectious disease (2446)
Inflammatory bowel disease (150)
Inflation Reduction Act (4)
Influenza (50)
Intellectual property (95)
Interviews (102)
IPO (13652)
IRA (13)
Job creations (2247)
Job search strategy (598)
Kidney cancer (11)
Labor market (22)
Layoffs (331)
Leadership (9)
Legal (3801)
Liver cancer (70)
Lung cancer (329)
Lymphoma (149)
Machine learning (8)
Management (22)
Manufacturing (264)
MASH (68)
Medical device (13120)
Medtech (13125)
Mergers & acquisitions (14660)
Metabolic disorders (589)
Multiple sclerosis (80)
NASH (14)
Neurodegenerative disease (100)
Neuropsychiatric disorders (21)
Neuroscience (1944)
NextGen: Class of 2025 (5333)
Non-profit (3069)
Now hiring (23)
Obesity (279)
Opinion (165)
Ovarian cancer (75)
Pain (89)
Pancreatic cancer (86)
Parkinson's disease (155)
Partnered (19)
Patents (226)
Patient recruitment (118)
Peanut (44)
People (49051)
Pharmaceutical (45)
Pharmacy benefit managers (2)
Phase I (21417)
Phase II (29638)
Phase III (21440)
Pipeline (1294)
Policy (61)
Postmarket research (2099)
Preclinical (8166)
Press Release (66)
Prostate cancer (102)
Psychedelics (30)
Radiopharmaceuticals (262)
Rare diseases (367)
Real estate (4655)
Recruiting (28)
Regulatory (18276)
Reports (27)
Research institute (2223)
Resumes & cover letters (116)
Rett syndrome (5)
RNA editing (4)
RSV (31)
Schizophrenia (64)
Series A (136)
Series B (89)
Service/supplier (11)
Sickle cell disease (46)
Special edition (12)
Spinal muscular atrophy (145)
Sponsored (24)
Startups (3290)
State (2)
Stomach cancer (12)
Supply chain (48)
Tariffs (12)
The Weekly (32)
Vaccines (583)
Venture capitalists (30)
Weight loss (152)
Women's health (30)
Worklife (8)
Date
Today (219)
Last 7 days (883)
Last 30 days (2896)
Last 365 days (30951)
2025 (11036)
2024 (33486)
2023 (38319)
2022 (48870)
2021 (51980)
2020 (48740)
2019 (40058)
2018 (30126)
2017 (29511)
2016 (27747)
2015 (32470)
2014 (24453)
2013 (19504)
2012 (20756)
2011 (21355)
2010 (19901)
Location
Africa (511)
Alabama (52)
Alaska (7)
Arizona (168)
Arkansas (14)
Asia (35342)
Australia (6318)
California (6131)
Canada (1837)
China (512)
Colorado (257)
Connecticut (278)
Delaware (137)
Europe (79484)
Florida (858)
Georgia (199)
Idaho (52)
Illinois (456)
India (22)
Indiana (309)
Iowa (7)
Japan (168)
Kansas (95)
Kentucky (24)
Louisiana (9)
Maine (27)
Maryland (807)
Massachusetts (4553)
Michigan (231)
Minnesota (363)
Mississippi (2)
Missouri (81)
Montana (31)
Nebraska (20)
Nevada (61)
New Hampshire (68)
New Jersey (1620)
New Mexico (29)
New York (1715)
North Carolina (966)
North Dakota (8)
Northern California (2692)
Ohio (191)
Oklahoma (14)
Oregon (38)
Pennsylvania (1285)
Puerto Rico (12)
Rhode Island (26)
South America (756)
South Carolina (25)
South Dakota (1)
Southern California (2340)
Tennessee (89)
Texas (930)
United States (22517)
Utah (177)
Virginia (141)
Washington D.C. (46)
Washington State (548)
West Virginia (3)
Wisconsin (55)
584,254 Results for "almac clinical technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Formosa Pharmaceuticals and Almac Discovery Announce Licensing Agreement for ALM-401, a First-in-Class Bispecific ADC targeting EGFR/ROR1 for the Treatment of Solid Tumors
May 7, 2025
·
3 min read
Press Releases
Almac Acquires Your Research to expand eClinical Solutions for Participants, Sites and Sponsors
December 11, 2024
·
1 min read
Almac Group signs virtual power purchase agreement (VPPA) for renewable energy – reducing their global scope 2 emissions by 46%
Almac Group today announced a 15-year virtual power purchase agreement (VPPA) with renewable energy provider
February 6, 2024
·
2 min read
Almac Pharma Services Invests £65m in Drug Product Manufacturing Expansion at Global Headquarter Facility
Almac Pharma Services, a member of the Almac Group providing innovative pharmaceutical development, manufacture and commercial services, has announced it is entering the final
October 19, 2023
·
3 min read
Press Releases
Privo Technologies Expands CLN-004 Clinical Trial Across Leading U.S. Cancer Centers
April 29, 2025
·
2 min read
Business
THREAD and Almac Clinical Technologies Partner to Eliminate Common Clinical Trial Delays
THREAD, a technology and service provider enabling decentralized clinical trials (DCTs), and Almac Clinical Technologies, a member of the contract and development organization, Almac Group, today announced a strategic partnership.
July 28, 2021
·
4 min read
Press Releases
Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia
April 24, 2025
·
4 min read
Press Releases
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial
April 3, 2025
·
4 min read
Press Releases
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
April 30, 2025
·
4 min read
Press Releases
Clinical Trial Technology and Services Market Size to Hit USD 110.48 Billion by 2034
February 28, 2025
·
1 min read
1 of 58,426
Next
